Thursday, September 3, 2009

Pfizer agrees record fraud fine

This article is a good example to use as support for various important BaM topics –

a) An example of the dangers of poor marketing strategy. Pizer has been fined for off-label promoting – that is – for promoting its products for uses that had NOT been approved by its external regulator (the US Federal Drugs Agency)

b) An example of possible diseconomies of scale – Pizer is the worlds largest drug producer: as such the business hay have suffered communication problems in making sure that the ruling by the FDA clearly prevented the firm from promoting its products for non- approved usage

c) An example of effective contingency planning – Pizers share price has remained unaffected by this news because the company had already put aside money to cover any fines in its 4th quarter in 2008

No comments: